Serum adropin levels are reduced in patients with inflammatory bowel diseases
Abstract Adropin is a novel peptide mostly associated with energy homeostasis and vascular protection. To our knowledge, there are no studies that investigated its relationship with inflammatory bowel diseases (IBD). The aim of this study was to compare serum adropin levels between 55 patients with...
Main Authors: | Darko Brnić, Dinko Martinovic, Piero Marin Zivkovic, Daria Tokic, Ivana Tadin Hadjina, Doris Rusic, Marino Vilovic, Daniela Supe-Domic, Ante Tonkic, Josko Bozic |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-66254-9 |
Similar Items
-
Serum Adropin Levels in Patients on Hemodialysis
by: Dijana Boric-Skaro, et al.
Published: (2021-04-01) -
Mediterranean Diet Adherence and Dietary Attitudes in Patients with Inflammatory Bowel Disease
by: Josip Vrdoljak, et al.
Published: (2020-11-01) -
Role of Adropin in Cardiometabolic Disorders: From Pathophysiological Mechanisms to Therapeutic Target
by: Josko Bozic, et al.
Published: (2021-10-01) -
Expression of CD44 in Leukocyte Subpopulations in Patients with Inflammatory Bowel Diseases
by: Ivana Franić, et al.
Published: (2022-08-01) -
Serum Adropin Levels in Patients with Rheumatoid Arthritis
by: Petra Simac, et al.
Published: (2022-01-01)